From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
Caregiver care costs
Productivity costs
Indirect costs
pre-PP1M (¥)
3830±3260
11,767±8133
15,967±10,128
Post-PP1M (¥)
2141±4044
8137±8150
10,279±11,878
Difference
-44.10%
-30.85%
-35.62%
P
≤ 0.01
< 0.01